TITLE

FDA delays hinder Guidant

AUTHOR(S)
Jefferson
PUB. DATE
December 1999
SOURCE
Indianapolis Business Journal;12/13/99, Vol. 20 Issue 40, p1A
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Focuses on developments related to Indianapolis, Indiana-based medical apparatus vendor Guidant Corp. as of December 13, 1999. Drop in the price of the company's stock caused by the delay in the United States Food and Drug Administration's (FDA) approval of the company's TriStar coronary stent; Delay in the FDA approval for the company's Prizm implantable defibrillator.
ACCESSION #
2643449

 

Related Articles

  • Boston Scientific: Guidant to rebound from product recall setbacks.  // PharmaWatch: Monthly Review;May2006, Vol. 5 Issue 5, p16 

    The article reports on the business performance of medical device maker Guidant Corp. The company is forecast to regain market share in the cardiac rhythm management (CRM) market, boosted by the rebound of the implantable cardioverter defibrillator market and its pending acquisition by Boston...

  • Guidant Panel's Advice May Help Beyond ICDs.  // Medical Design Technology;Oct2005, Vol. 9 Issue 11, p9 

    The article reports that an independent panel created by Guidant Corp. is set to conduct a case study on the company's handling of implantable cardioverter defibrillator (ICD) safety communications by February 2006. While the study will focus on the company's ICD business, the panel is hoping...

  • Guidant lagging in new stent race. Culbertson, Katie // Indianapolis Business Journal;2/12/2001, Vol. 21 Issue 49, p1 

    Reports on the business performance of Indianapolis, Indiana-based medical device maker Guidant Corp. Strides in the frontier of drug-coated coronary stents; Guidant's release of an initial progress report on its coated stents; Possibility of market erosion for Guidant when the coated variety...

  • Stuck with the check? Becker, Cinda // Modern Healthcare;6/27/2005, Vol. 35 Issue 26, p20 

    Reports on the recall of implantable cardiac defibrillators (ICD) by Guidant Corp. in the U.S. in June 2005. Cost of the device; Background on ICD; Problems encountered by patients at Indiana Heart Hospital in Indianapolis with the device.

  • Heart implant recall shakes patients. Webster, Richard A. // New Orleans CityBusiness (1994 to 2008);7/11/2005, Vol. 25 Issue 53, p1 

    Reports on the increasing telephone calls from terrified patients following the recall of cardiac defibrillators by cardiovascular product manufacturer Guidant Corp. in the U.S. Discovery of flaw that could prevent the devices from delivering a life-saving shock to the heart; Payment of patient...

  • Boston Scientific ICD recalls.  // Materials Management in Health Care;Aug2006, Vol. 15 Issue 8, p8 

    The article reports that Massachusetts-based Boston Scientific Corp. is continuing the recall of certain models of cardiac resynchronization pacemakers and implantable cardioverter defibrillators produced by Guidant, which was acquired by Boston. The United States Food and Drug Administration...

  • Boston Sci sees up-tick in Guidant ICD-related suits.  // Medical Technology & Devices Week;3/12/2007, Vol. 5 Issue 11, p3 

    The article focuses on reports from Boston Scientific about the increase in the number of lawsuits against Guidant's heart rhythm devices. The company now faces more than 1,100 individual and 75 class action lawsuits over recalls and safety warnings issued in 2005 and 2006 involving Guidant's...

  • Boston Sci's Guidant unit in $296 million settlement.  // Medical Device Daily;4/7/2010, Vol. 14 Issue 66, p2 

    The article reports on a guilty plea made by the Boston Scientific's Guidant unit to criminal violations of the Federal Food, Drug and Cosmetic Act. The admission was made by the medical device manufacturer in St. Paul, Minnesota, before U.S. District Court Judge Donovan Frank, following a...

  • Guidant reports failure modes on certain pacemakers.  // Materials Management in Health Care;Nov2005, Vol. 14 Issue 11, p7 

    The article presents information on physician advisory related to failure of defibrillator models of certain pacemakers in the U.S. Guidant Corp. says that the failure models may result in different device behavior. This model failure may result in intermittent or permanent loss of pacing output...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics